Escitalopram Dosing for Panic Disorder with Agoraphobia
Start escitalopram at 5-10 mg once daily and titrate to a target dose of 10-20 mg/day for panic disorder with agoraphobia in adults.
Initial Dosing Strategy
Begin with 5-10 mg once daily 1. The lower starting dose (5 mg) is particularly advisable because SSRIs can initially cause anxiety or agitation as an adverse effect 2. This "test dose" approach helps minimize early treatment-emergent anxiety that could worsen panic symptoms.
Administer once daily, morning or evening, with or without food 3.
Titration Schedule
- Week 1-2: Start at 5-10 mg daily
- Week 2-4: If tolerated, increase to 10 mg daily (if not already at this dose)
- After 3+ weeks at 10 mg: Consider increasing to 20 mg daily if response is inadequate 3
The FDA label specifies that dose increases to 20 mg should occur after a minimum of one week for generalized anxiety disorder 3, though panic disorder may warrant the more conservative 3-week interval used in depression trials.
Target Therapeutic Dose
The effective dose range is 10-20 mg/day 1, 4. In the pivotal randomized controlled trial for panic disorder, escitalopram was flexibly dosed at 5-10 mg/day, with the frequency of panic attacks significantly improved compared to placebo (p=0.04) 1. Network meta-analyses confirm escitalopram provides high remission rates with acceptable adverse event risk 4.
Evidence Supporting This Approach
The strongest evidence comes from a 10-week double-blind RCT (N=366) where escitalopram 5-10 mg/day significantly reduced panic attack frequency and improved panic disorder symptoms versus placebo 1. Notably, 50% of escitalopram recipients versus 38% of placebo recipients experienced zero panic attacks 1. The drug demonstrated faster onset of action than citalopram and was well-tolerated with only 6.3% discontinuation due to adverse events 1.
Recent network meta-analyses position escitalopram favorably: among SSRIs, sertraline and escitalopram provide high remission with low adverse event risk 4. While benzodiazepines and tricyclics may show slightly higher efficacy, SSRIs as a class offer the best balance of effectiveness and tolerability 5, 4.
Special Populations
- Elderly patients: Use 10 mg/day as the recommended dose 3
- Hepatic impairment: Use 10 mg/day 3
- Severe renal impairment: Use with caution; no specific dose adjustment provided but lower doses prudent 3
Duration of Treatment
Continue treatment for several months beyond acute response. While systematic long-term data specific to panic disorder are limited, maintenance efficacy can be extrapolated from depression studies where continued treatment significantly reduced relapse risk 3. Periodically reassess the need for ongoing treatment 3.
Key Safety Considerations
- Screen for bipolar disorder before initiating treatment 3
- Monitor for suicidal ideation, especially in the first months and after dose changes (boxed warning through age 24) 2
- Watch for behavioral activation/agitation early in treatment, particularly in younger patients 2
- Avoid abrupt discontinuation: Taper gradually to minimize withdrawal symptoms 3
- Drug interactions: Escitalopram has the least effect on CYP450 enzymes among SSRIs, reducing interaction risk 2
- Contraindicated with MAOIs: Allow 14 days between MAOI discontinuation and escitalopram initiation 3
Clinical Pearls
Escitalopram's high serotonin selectivity and favorable pharmacokinetic profile make it particularly suitable for panic disorder 6. The long elimination half-life permits once-daily dosing 2. Expect clinically significant improvement by week 6 and maximal improvement by week 12 2, though some patients show earlier response 1.
Common adverse effects include nausea (15%), insomnia (9%), and sexual dysfunction (9% ejaculatory delay in males) 3, but these are generally mild and manageable with dose adjustment or time.